Literature DB >> 9720715

Role of umbilical vein endothelial cells in hematopoiesis.

H Yamaguchi1, E Ishii, K Tashiro, S Miyazaki.   

Abstract

Effective hematopoiesis is usually induced by interactions between hematopoietic progenitor cells (HPC) and stromal cells. In cord blood (CB), umbilical vein endothelial cells (HUVEC) can support HPC as a stromal microenvironment. EC activated mainly by IL-1 and TNFalpha produce a variety of cytokines and growth factors such as IL-1, IL-4, IL-6, GM-CSF and G-CSF. Since HPC express c-kit on their surface, the SCF produced by HUVEC plays an important role in the hematopoiesis of CB. We examined the expression of cytokines and growth factors on HUVEC by PCR. Resting HUVEC expressed high level of SCF, and low levels of IL-6, IL-7, and IL-8. Thus, a variety of cytokines and growth factors are produced by EC, and this cytokine network is thought to play an important role in regulating hematopoiesis. Activated EC can also express various adhesion molecules including E-selectin, VCAM-1 and ICAM-1, and facilitate the adhesion of hematopoietic cells to the endothelium. Furthermore, the interaction of CB cells with HUVEC has recently been shown in vitro. We previously showed that the culture media of HUVEC induced high numbers of colony formation. Suitable cytokine productions are thus provided to HPC by the interaction of HUVEC and cord MNC. On the basis of these findings, several mechanisms to support hematopoiesis in CB can be considered. Specific growth factors produced by EC bind to HPC to induce proliferation. While cell-cell interactions involve adhesion of HPC to HUVEC via adhesion molecules, and the adhesion of HPC to EC will facilitate interaction with cytokines and growth factors. Thus HPC in CB proliferate and are maintained by growth factors, and adhesion molecules produced by HUVEC, and HPC themselves.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720715     DOI: 10.3109/10428199809057585

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  9 in total

1.  Immunohistochemical and transcriptional expression of matrix metalloproteinases in full-term human umbilical cord and human umbilical vein endothelial cells.

Authors:  Annamaria Mauro; Maria Buscemi; Aldo Gerbino
Journal:  J Mol Histol       Date:  2010-10-10       Impact factor: 2.611

2.  mTOR regulates cell survival after etoposide treatment in primary AML cells.

Authors:  Qing Xu; James E Thompson; Martin Carroll
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 3.  The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine.

Authors:  N Forraz; C P McGuckin
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

4.  Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.

Authors:  Prasad S Koka; Christina M R Kitchen; Srinivasa T Reddy
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  An aryl hydrocarbon receptor agonist suppresses the growth of human umbilical vein endothelial cells in vitro: Potent effect with polyunsaturated fatty acids.

Authors:  Masayoshi Yamaguchi; Oliver Hankinson
Journal:  Int J Exp Pathol       Date:  2020-09-28       Impact factor: 1.925

6.  Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis.

Authors:  Kuan-Hung Lin; Ya-Hsuan Ho; Jui-Chung Chiang; Meng-Wei Li; Shi-Hung Lin; Wei-Min Chen; Chi-Ling Chiang; Yu-Nung Lin; Ya-Jan Yang; Chiung-Nien Chen; Jenher Lu; Chang-Jen Huang; Gabor Tigyi; Chao-Ling Yao; Hsinyu Lee
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

7.  Modeling Uremic Vasculopathy With Induced Pluripotent Stem Cell-Derived Endothelial Cells as a Drug Screening System.

Authors:  Hye Ryoun Jang; Hyung Joon Cho; Yang Zhou; Ning-Yi Shao; Kyungho Lee; Hoai Huong Thi Le; Junseok Jeon; Jung Eun Lee; Wooseong Huh; Sang-Ging Ong; Won Hee Lee; Yoon-Goo Kim
Journal:  Front Cell Dev Biol       Date:  2021-01-12

8.  Hematopoietic progenitor cells and interleukin-stimulated endothelium: expansion and differentiation of myeloid precursors.

Authors:  Anja Moldenhauer; Gesche Genter; Andreas Lun; Gürkan Bal; Holger Kiesewetter; Abdulgabar Salama
Journal:  BMC Immunol       Date:  2008-10-01       Impact factor: 3.615

9.  A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment.

Authors:  Daniel Ryan; Abhilasha Sinha; Danielle Bogan; Joanna Davies; Jim Koziol; Wael M ElShamy
Journal:  Oncotarget       Date:  2017-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.